The global bioengineered protein drugs market size valued 150.5 billion in 2020, growing at a CAGR of 3.4% during the forecast period 2021-2027. Bioengineered proteins are formulated as the fundamental participants in the biological process. They are target specific and have lesser side effects which leads to higher acceptance when compared to that of a small molecule. Bioengineered Protein Drugs Market act as the powerful therapeutic agents. They include a wide range of products such as monoclonal antibodies, cytokines, growth factors, and many. Due to various factors such as bio-reactivity, safety, and success rate bioengineered proteins are gaining popularity all across the healthcare industry.